Turning Point Therapeutics, Inc. SG&A Expenses 2019-2022 | TPTX
Turning Point Therapeutics, Inc. sg&a expenses from 2019 to 2022. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Turning Point Therapeutics, Inc. Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2021 | $76 |
| 2020 | $73 |
| 2019 | $20 |
| 2018 | $5 |
| 2017 | $1 |
| Turning Point Therapeutics, Inc. Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2022-06-30 | $38 |
| 2022-03-31 | $20 |
| 2021-12-31 | $20 |
| 2021-09-30 | $18 |
| 2021-06-30 | $17 |
| 2021-03-31 | $20 |
| 2020-12-31 | $14 |
| 2020-09-30 | $11 |
| 2020-06-30 | $9 |
| 2020-03-31 | $40 |
| 2019-12-31 | $6 |
| 2019-09-30 | $6 |
| 2019-06-30 | $5 |
| 2019-03-31 | $4 |
| 2018-12-31 | $2 |
| 2018-09-30 | $1 |
| 2018-06-30 | $1 |
| 2018-03-31 | $1 |
